Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich prominent research institution will lead further research on the Brazilian gene discovery by end of 2025?
Harvard University • 25%
Oxford University • 25%
Johns Hopkins University • 25%
Other • 25%
Research publications and institutional announcements
Brazilian Scientists Discover Gene That May Protect Against COVID-19
Dec 2, 2024, 12:53 PM
Brazilian scientists have made a significant breakthrough by discovering a gene that may provide protection against COVID-19. This finding has been reported by multiple sources, indicating its potential implications for public health and medical research. The gene's discovery could lead to advancements in treatments and preventative measures against the virus, enhancing the scientific community's understanding of COVID-19 and its effects on the human body. This development is part of ongoing research efforts to combat the pandemic and improve health outcomes.
View original story
Harvard University • 25%
MIT • 25%
Stanford University • 25%
Other • 25%
Harvard University • 25%
Stanford University • 25%
Max Planck Institute • 25%
Other • 25%
MIT • 25%
Harvard • 25%
Stanford • 25%
Other • 25%
MIT • 25%
Harvard Medical School • 25%
Massachusetts General Hospital • 25%
Other • 25%
University of Florence • 25%
Harvard University • 25%
Max Planck Institute • 25%
Other • 25%
Significant reduction in illicit gold trade • 25%
Moderate reduction in illicit gold trade • 25%
No significant impact • 25%
Increase in illicit gold trade • 25%
ADHD • 25%
Schizophrenia • 25%
Bipolar Disorder • 25%
Parkinson’s Disease • 25%
Elephant genome • 25%
Blue whale genome • 25%
Komodo dragon genome • 25%
Other • 25%
Yes • 50%
No • 50%
MIT • 25%
Stanford University • 25%
Max Planck Institute • 25%
Other • 25%
23andMe • 25%
AncestryDNA • 25%
MyHeritage • 25%
Other company • 25%
Parks Canada • 25%
University of Cambridge • 25%
National Geographic Society • 25%
Other • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
AstraZeneca • 25%
Pfizer • 25%
Other • 25%
Moderna • 25%